This information is useful for children, adults, and older adults
Why Yale Medicine?
  • Yale Medicine has pioneered early interventions for schizophrenia.
  • Several specialized Yale Medicine clinics offer advanced treatment for schizophrenia that are not available elsewhere.
  • Interventions for schizophrenia are based on the latest brain and psychology research available.
  • Our physicians and healthcare staff are trained to provide calm, supportive care.

About one in 100 American adults has schizophrenia, according to the National Institute of Mental Health. Physicians and therapists tend to think of schizophrenia as a spectrum of disorders, much like autism - which incorporates a wide range in symptoms and levels of impairment. Even though much progress has been made toward a better understanding of schizophrenia, researchers acknowledge that in many respects the disease remains a black box. 

“It’s not one disease; it’s probably many different diseases,” says Vinod Srihari, MD, associate professor of psychiatry at Yale School of Medicine and director of the Specialized Treatment Early in Psychosis (STEP) program. Early, intensive treatment may lead to better outcomes for patients over time. With the right care, Dr. Srihari says, most patients with schizophrenia are able to manage their symptoms and live productive lives.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.